News, views and contacts from the global Drugdevelopment industry

Fujifilm Diosynth Biotechnologies: Press Releases

Make An Enquiry

New Mammalian cGMP Cell Banking Facility Commissioned by Fujifilm Diosynth Biotechnologies Tuesday, April 30, 2013 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has announced that it has commissioned on time its new mammalian cGMP Cell Banking Facility (CBF) at its Billingham, UK site....

New Licensed Biopharmaceutical Manufactured by Fujifilm Diosynth Biotechnologies Wednesday, November 14, 2012 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has added another licensed product to its list of commercial biopharmaceutical products, following the announcement that ThromboGenics' has received FDA...

Fujifilm Diosynth Biotechnologies Partners With Piramal Healthcare to Produce Antibody Drug Conjugates Wednesday, November 14, 2012 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract development...

Fujifilm Diosynth Biotechnologies Significantly Expands Mammalian Cell Culture CGMP Capabilities Tuesday, June 26, 2012 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in mammalian cell...

Fujifilm Diosynth Biotechnologies Invests in New Equipment and Labs at UK Facility Tuesday, April 03, 2012 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has completed the first phase of a £3m ($4.5m) investment in new equipment and laboratories at its Billingham, UK...

Fujifilm Diosynth Biotechnologies and ContraFect Corporation Announce Development and Manufacturing Collaboration for Novel Anti-Staph Biologic Monday, October 31, 2011 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies and ContraFect Corporation have announced that they have signed a contract to support the process development and cGMP manufacture of...

Fujifilm Diosynth Biotechnologies Expands its Mammalian Cell Culture Capacity Friday, June 10, 2011 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies is expanding its existing contract manufacturing capabilities with the addition of a 1,000l Xcellerex® single-use bioreactor to its RTP, North...

Fujifilm Diosynth Biotechnologies Announced as New Name for MSD BioManufacturing Network Wednesday, April 06, 2011 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has been announced as the new name for the former Merck BioManufacturing Network (known as MSD BioManufacturing Network outside the US and Canada)...

Fujifilm to Acquire MSD BioManufacturing Network Wednesday, March 09, 2011 by Fujifilm Diosynth Biotechnologies Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck...

Nuron Biotech Selects Merck BioManufacturing Network as Manufacturing Supplier for NU100 Thursday, February 10, 2011 by Fujifilm Diosynth Biotechnologies Nuron Biotech has selected the Merck BioManufacturing Network in the UK to manufacture large-scale GMP clinical supplies of NU100 and undertake process validation leading to long-term...